Breast Cancer Gene-Expression Miner v5.2
(bc-GenExMiner v5.2)

In order to support further development, please cite at least one of the following articles:

Online launch, "Prognostic" module
	bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer. Jézéquel P, Campone M, Gouraud W, Charbonnel C, Leux C, Ricolleau G, Campion L. Breast Cancer Res Treat 2012;131:765-775.
"Correlation" module
	bc-GenExMiner 3.0: new mining module computes breast cancer gene-expression correlation analyses. Jézéquel P, Frénel JS, Campion L, Guérin-Charbonnel C, Gouraud W, Ricolleau G, Campone M. Database (Oxford) 2013;bas060.
"Expression" module
	bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. Jézéquel P, Gouraud W, Ben Azzouz F, Guérin-Charbonnel C, Juin P, Lasla H, Campone M. Database (Oxford) 2021;baab007.
TNBC subtyping
	Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype. Jézéquel P, Lasla H, Gouraud W, Basseville A, Michel B, Frenel J-S, Juin P, Ben Azzouz F, Campone M. Breast Cancer 2024;31:825-840.  Award of 2024 Best of Breast Cancer from the Japanese Breast Cancer Society

Examples:

	A novel peptide 66CTG stabilizes Myc proto-oncogene protein to promote triple-negative breast cancer growth. Liang H, Li F, Fang H, Ren W, Zhou Z, Wang J, Liu J, Tang Y, Liu X, Wu Y, Peng J, Yang C, Chen J, Fei Y, Shi Y, Jiang D, Zhang N, Chen C. Signal Transduct Target Ther 2025;10:217.
	The FUS/circEZH2/KLF5/ feedback loop contributes to CXCR4-induced liver metastasis of breast cancer by enhancing epithelial-mesenchymal transition. Liu P, Wang Z, Ou X, Wu P, Zhang Y, Wu S, Xiao X, Li Y, Ye F, Tang H. Mol Cancer 2022;21:198.
	Reuse of public genome-wide gene expression data. Rung J and Brazma A. Nat Rev Genet 2013;14:89-99.